Application of biological drug monitoring in the treatment of inflammatory bowel disease
生物制剂药物监测在炎症性肠病治疗中的应用

摘要

目的 分析在炎症性肠病治疗中采取生物制剂药物监测的应用效果。方法 抽取本院在 2022 年 2 月 -2023 年 2 月期间收治的 48 例炎症性肠病患者为本次研究对象，按照随机数字表法分为参考组及实验组，其中参 考组不采取生物制剂药物监测，实验组采取生物制剂药物监测护理，每组 24 例。观察比较两组护理效果。 结果 实验组治疗有效率为 95.83%，参考组治疗有效率为 54.17%，治疗有效率对比分析，实验组显高（P＜0.05）。 结 论 生物制剂药物监测护理干预在炎症性肠病临床用药、优化治疗方案方面可起到较好的价值，是实现炎症性肠 病精准化治疗的主要辅助手段，能够促进患者的治疗效果。

Abstract

Objective To analyze the application effect of biological drug monitoring in the treatment of inflammatory bowel disease. Method A total of 48 patients with inflammatory bowel disease admitted to our hospital from February 2022to February 20223were selected as the study subjects. They were randomly divided into a reference group and an experimental group using a random number table method. The reference group did not receive biopharmaceutical drug monitoring, while the experimental group received biopharmaceutical drug monitoring care, with 24 patients in each group. Observe and compare the nursing effects between the two groups. Result The effective rate of treatment in the experimental group was 95.83%, while the effective rate in the reference group was 54.17%. Comparative analysis of the effective rates showed that the experimental group had a significantly higher effective rate (P<0.05).
Conclusion   Biological drug monitoring and nursing interventions can play a good role in clinical medication and optimization of treatment plans for inflammatory bowel disease. They are the main auxiliary means for achieving precise treatment of inflammatory bowel disease and can promote the treatment effect of patients.